Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

New England Journal of Medicine

Volumn 334, Issue 21, 1996, Pages 1362-1366

  Scholes, Delia ^a,c   Stergachis, Andy ^c,e   Heidrich, Fred E ^b   Andrilla, Holly ^e   Holmes, King K ^d   Stamm, Walter E ^d  

^a CENTER FOR HEALTH STUDIES   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVICITIS;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; RISK FACTORS; UTERINE CERVICAL DISEASES;

EID: 0029897909     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605233342103     Document Type: Article

References (29)

1. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR Morb Mortal Wkly Rep 1993;42(RR-12):1-39.
2. Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 1990;12:199-220.
3. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993;69:9-17.
4. Expert Committee on Pelvic Inflammatory Disease. Pelvic inflammatory disease: research directions in the 1990s. Sex Transm Dis 1991;18:46-64.
5. Cates W Jr, Wasserheil JN, Marchbanks PA. Pelvic inflammatory disease and tubal infertility: the preventable conditions. Ann N Y Acad Sci 1994; 709:179-95.
6. Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;266:2574-80.
7. Cates W Jr, Meheus A. Strategies for development of sexually transmitted diseases control program. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:1023-30.
8. Rolfs RT. "Think PID": new directions in prevention and management of pelvic inflammatory disease. Sex Transm Dis 1991;18:131-2.
9. Stamm WE, Holmes KK. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. 2nded. New York: McGraw-Hill, 1990:181-93.
10. Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease: what are the questions? JAMA 1991;266:2587-93.
11. Webster LA, Greenspan JR, Nakashima AK, Johnson RE. An evaluation of surveillance for Chlamydia trachomatis infections in the United States - 1987-1991. MMWR CDC Surveill Summ 1993;42(SS-3):21-7.
12. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255:1730-4.
13. Phillips RS, Hanff PA, Holmes MD, Wertheimer A, Aronson MD. Chlamydia trachomatis cervical infection in women seeking routine gynecologic care: criteria for selective testing. Am J Med 1989;86:515-20.
14. Addiss DG, Vaughn ML, Davis JP. A diagnostic model for diagnosing chlamydial infection. JAMA 1991;265:1951-2.
15. Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA 1990;264:3161-5.
16. Vincelette J, Baril JG, Allard R. Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners. Can Med Assoc J 1991;144:713-21.
17. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993;138:143-53.
18. Saunders KW, Stergachis A, Von Korff M. Group Health Cooperative of Puget Sound. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, England: John Wiley, 1994:171-85.
19. Stamm WE, Tam M, Koester M, Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983;17:666-8.
20. Department of Health and Human Services. Healthy People 2000: national health promotion and disease prevention objectives 1990. Washington, D.C.: Government Printing Office, 1991. (DHHS publication no. (PHS) 91-50212.)
21. Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med 1987;107: 188-94.
22. Nettleman MD, Jones RB, Roberts SD, et al. Cost-effectiveness of culturing for Chlamydia trachomatis: a study in a clinic for sexually transmitted diseases. Ann Intern Med 1986;105:189-96.
23. Trachtenberg AI, Washington AE, Halldorson S. A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol 1988;71:101-8.
24. Buhaug H, Skjeldestad FE, Backe B, Dalen A. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care 1989;27:833-41.
25. Buhaug H, Skjeldestad FE, Halvorsen LE, Dalen A. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract 1990;40:142-5.
26. Malotte CK, Wiesmeier E, Gelineau KJ. Screening for chlamydial cervicitis in a sexually active university population. Am J Public Health 1990;80:469-71.
27. Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V. Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 1990;66:812-8.
28. Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113-4.
29. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease: a comprehensive analysis and considerations for developing a new model. JAMA 1991;266:2594-604.